LICA PHARMACEUTICALS ApS: Financial statements 2020
CVR: 25332520
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 326,213 and a net result of DKK 843,617 compared with DKK 2,782,288 the year before. That is an increase of 16.6% compared with the year before. Equity in the 2020 report amounted to DKK 19,593,671. The solvency ratio was 99.3%.
- Gross Profit
- DKK 326,213
- Profit/Loss
- DKK 843,617
- Equity
- DKK 19,593,671
- Total Assets
- DKK 19,737,400
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 326 t. | 844 t. | 19.6 mio. | 0 |
| 2019 | - | 280 t. | 2.8 mio. | 18.8 mio. | - |
| 2018 | - | 973 t. | 5.6 mio. | 18.4 mio. | - |
| 2017 | - | 409 t. | 812 t. | 12.8 mio. | - |
| 2016 | - | 738 t. | 328 t. | 12 mio. | - |
Official annual report
How creditworthy is LICA PHARMACEUTICALS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 31, 2020, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of LICA PHARMACEUTICALS ApS.
As of December 31, 2020, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of LICA PHARMACEUTICALS ApS.
LICA PHARMACEUTICALS ApS has published its annual report for 2019. Gross profit came to DKK 279,654, and the net result was DKK 2,782,288.
About LICA PHARMACEUTICALS ApS
LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The company has 1 employee (2013). In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity in the 2025 report amounted to DKK 24,221,286.